CSIMarket
 


Kintara Therapeutics Inc   (KTRA)
Other Ticker:  
 
 

KTRA's EPS Net Growth by Quarter and Year

Kintara Therapeutics Inc 's EPS Net results by quarter and year




KTRA EPS Net (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - -2.03 -0.09 -2.36
III Quarter March - -1.94 -0.11 0.23
II Quarter December - -2.10 0.12 0.22
I Quarter September -1.83 -0.07 0.25 1.33
FY   -1.83 -6.14 0.17 -0.58



KTRA EPS Net first quarter 2024 Y/Y Growth Comment
Kintara Therapeutics Inc in the first quarter 2024 recorded EPS net loss of $ -1.83 .

According to the results reported in the first quarter 2024, Kintara Therapeutics Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Kintara Therapeutics Inc ' s EPS Net no change of % ranks overall at the positon no. in the first quarter 2024.




KTRA EPS Net ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - 35.29 %
II Quarter December - - -45.45 % 46.67 %
I Quarter September - - -81.2 % 533.33 %
FY   - - - -

Financial Statements
Kintara Therapeutics Inc 's first quarter 2024 EPS Net $ -1.83 KTRA's Income Statement
Kintara Therapeutics Inc 's first quarter 2023 EPS Net $ -0.07 Quarterly KTRA's Income Statement
New: More KTRA's historic EPS Net Growth >>


KTRA EPS Net (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - 4.55 %
II Quarter December - - -52 % -83.46 %
I Quarter September - - - -
FY (Year on Year)   - - - -




EPS Net first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Kintara Therapeutics Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KTRA's I. Quarter Q/Q EPS Net Comment
Despite the fact, that Kintara Therapeutics Inc in the I. Quarter 2024 admitted EPS net loss of $ -1.83 , some analyst point out, that this point to slight up side in contrast to the -2.03 in the fourth quarter.

Within Major Pharmaceutical Preparations industry Kintara Therapeutics Inc achieved highest sequential EPS Net growth. While Kintara Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KTRA's I. Quarter Q/Q EPS Net Comment
Even if Kintara Therapeutics Inc in the I. Quarter 2024 admitted EPS net loss of $ -1.83 , management point out, that this point to slight up side relative to the -2.03 in the fourth quarter.

Within Major Pharmaceutical Preparations industry Kintara Therapeutics Inc achieved highest sequential EPS Net growth. While Kintara Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


Kintara Therapeutics Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS Net 12 Months Ending $ -7.90 $ -6.14 $ -4.20 $ -2.37 $ -0.15
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Kintara Therapeutics Inc ' has realized cumulative trailing twelve months EPS net loss of $ -8 in the Sep 30 2023 period.
The business is detiriorating as the cumulative EPS net loss is getting bigger from $ -6.14 in the twelve months ending a quarter before and $ 0.17334499761412 from the TTM period ending Sep 30 2022 Donna García  told.

Kintara Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Kintara Therapeutics Inc ' has realized cumulative trailing twelve months EPS net loss of $ -8 in the Sep 30 2023 period.
The results are getting worse as the cumulative EPS net loss is getting bigger from $ -6.14 for the period from Jun 30 2023 to Sep 30 2022 and $ 0.17334499761412 for the twelve months ending in the quarter Sep 30 2022.

Kintara Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
KTRA's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for KTRA's Competitors
EPS Net Growth for Kintara Therapeutics Inc 's Suppliers
EPS Net Growth for KTRA's Customers

You may also want to know
KTRA's Annual Growth Rates KTRA's Profitability Ratios KTRA's Asset Turnover Ratio KTRA's Dividend Growth
KTRA's Roe KTRA's Valuation Ratios KTRA's Financial Strength Ratios KTRA's Dividend Payout Ratio
KTRA's Roa KTRA's Inventory Turnover Ratio KTRA's Growth Rates KTRA's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2023
Radnet Inc 2,400.00%$ 2,400.000 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com